Home Cart 0 Sign in  
X

[ CAS No. 1129-28-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 1129-28-8
Chemical Structure| 1129-28-8
Chemical Structure| 1129-28-8
Structure of 1129-28-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1129-28-8 ]

Related Doc. of [ 1129-28-8 ]

Alternatived Products of [ 1129-28-8 ]

Product Details of [ 1129-28-8 ]

CAS No. :1129-28-8 MDL No. :MFCD00051437
Formula : C9H9BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :YUHSMQQNPRLEEJ-UHFFFAOYSA-N
M.W : 229.07 Pubchem ID :517981
Synonyms :

Calculated chemistry of [ 1129-28-8 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 50.56
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.6 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.44
Log Po/w (XLOGP3) : 2.96
Log Po/w (WLOGP) : 2.22
Log Po/w (MLOGP) : 2.7
Log Po/w (SILICOS-IT) : 2.71
Consensus Log Po/w : 2.6

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.3
Solubility : 0.116 mg/ml ; 0.000505 mol/l
Class : Soluble
Log S (Ali) : -3.18
Solubility : 0.153 mg/ml ; 0.000668 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.74
Solubility : 0.0419 mg/ml ; 0.000183 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.82

Safety of [ 1129-28-8 ]

Signal Word:Danger Class:8
Precautionary Statements:P501-P260-P234-P264-P280-P390-P312-P303+P361+P353-P301+P330+P331-P363-P304+P340+P310-P305+P351+P338+P310-P406-P405 UN#:3261
Hazard Statements:H303-H314-H290 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1129-28-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1129-28-8 ]
  • Downstream synthetic route of [ 1129-28-8 ]

[ 1129-28-8 ] Synthesis Path-Upstream   1~33

  • 1
  • [ 99-36-5 ]
  • [ 1129-28-8 ]
YieldReaction ConditionsOperation in experiment
95% With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane at 70℃; 30mL CCl4The 7.9g inter-methylbenzoate was dissolved in dry 100mL three-necked flask, AIBN (azobisisobutyronitrile) 0.23g, 9.36gNBS (bromosuccinimide) three times into the reaction system ( was added in two intervals of about 2-3h), heated to 70 , the reaction from the system during the final yellow to orange to white, TLC tracking (eluent: cyclohexane: ethyl acetate = 5) to be reaction was almost complete, the succinimide was removed by filtration and the unreacted bromosuccinimide, the resultant filtrate rotary evaporated to give 11.5 g of product as a yellow oil, 95percent yield.
94% With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethaneReflux A solution of methyl 3-methylbenzoate (47 g, 0.31 mol) in CCl4 (200 mL) was heated to reflux followed by addition of AIBN (2.6 g) in one portion. After that, NBS (67 g, 0.38 mol) was added carefully to the mixture during 2 h, and then the reaction was refluxed for an additional 5 h. After cooling to r.t. the mixture was filtered and evaporated under vacuum to give methyl 3-(bromomethyl)benzoate (10, 67 g, Yield: 94percent) as a yellowish oil. The obtained oil was then dissolved in triethyl phosphate (130 g, 0.71 mol), heated to 160 °C and kept at this temperature for an additional 10 h. The mixture was concentrated on a rotary evaporator and then purified by flash chromatography(PE:EA = 5:1~PE:EA = 1:3) to give 11 as a yellow oil, which was used without any further purification.
94% With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane at 80℃; for 16 h; To a solution of methyl 3-methylbenzoate (4.0 g, 26.60 mmol) in CCU (150 mL) was added BS (5.69 g, 31.96 mmol), and the suspension was heated at 80 °C for 5 min and AIBN (2.18 g, 13.30 mmol) was added. The suspension continued to stir at 80 °C for 16 h. The mixture was cooled to RT and filtered. The filtrate was concentrated to give the crude product, which was purified by silica gel chromatography eluting with EA/petroleum ether from 0percent to 3percent to give methyl 3-(bromomethyl)benzoate (5.7 g, 94percent) as a white oil
91% With N-Bromosuccinimide In tetrachloromethane at 50℃; for 5 h; Heating / reflux To a mixture of methyl-m-toluate (180 g, 1.2 mol) and N-bromosuccimide (235 g, 1.32 mol) in CCl4 (2 L) was added in portion benzoyl peroxide (18 g, 0.1 times) at 50° C. The mixture was refluxed for 5 h. Then the mixture was allowed to cool down to 40° C. and the solid was filtered off. The filtrate was concentrated to give methyl 3-(bromomethyl)benzoate (252 g, 91percent) as light yellow liquid.
87% With N-Bromosuccinimide; dibenzoyl peroxide In tetrachloromethane at 70℃; for 4 h; To a solution of Intermediate BL (5.0g, 33.29 mmol) and benzoyl peroxide (0.4 g, 1.66 mmol) in CC14 (60.0 mL) was added NBS (5.75 g, 33.29 mmol). The reaction mixture was stirred at 70 °C for 4 hours. The reaction mixture was filtered, and the filtrate was concentrated to obtain the crude product. This material was purified by column chromatography (silica gel 100-200 mesh) using 1percent ethyl acetate in petroleum ether as the eluent to afford Intermediate BM (6.8 g, 87percent) as pale yellow oil. NMR (CDC13): δ 8.07 (s, 1H), 8.00-7.96 (m, 1H), 7.60-7.58 (m, 1H), 7.43 (t, J= 7.67 Hz, 1H), 4.52 (s, 2H), 3.93 (s, 3H).
10% With N-Bromosuccinimide In cyclohexane for 16 h; Reflux Synthesis Example 11; Synthesis of Compound 22; Methyl-3-methyl benzoate (1.5 g, 10 mmol) and N-bromosuccinimide (5.34 g, 30 mmol) was suspended in cyclohexane (50 ml). To the suspension, a catalytic amount of hydrogen peroxide was added, and the reaction mixture was heated to reflux for 16 h. The reaction mixture was then filtered, and evaporated to yield 0.231 g (10percent) as a yellow oil. Compound 21 was then formed by coupling methyl 3-bromomethylbenzoate to thionicotinamide intermediate IIa in the manner of Method A to yield 180 mg (45percent) of compound 22 as a crystalline material. ESI-MS m/z=397.1 [M+H]+.
10% With N-Bromosuccinimide; dihydrogen peroxide In cyclohexane for 16 h; Reflux Methyl-3-methyl benzoate (1.5 g, 10 mmol) and N-bromosuccinimide (5.34 g, 30 mmol) was suspended incyclohexane (50 ml). To the suspension, a catalytic amount of hydrogen peroxide was added, and the reaction mixturewas heated to reflux for 16 h. The reaction mixture was then filtered, and evaporated to yield 0.231 g (10percent) as a yellowoil. Compound 21 was then formed by coupling methyl 3-bromomethylbenzoate to thionicotinamide intermediate IIa inthe manner of Method A to yield 180 mg (45percent) of compound 22 as a crystalline material. ESI-MS m/z = 397.1 [M+H]+.

Reference: [1] Organic and Biomolecular Chemistry, 2003, vol. 1, # 14, p. 2506 - 2511
[2] Patent: CN106146413, 2016, A, . Location in patent: Paragraph 0027; 0028
[3] European Journal of Medicinal Chemistry, 2009, vol. 44, # 1, p. 7 - 17
[4] Molecules, 2016, vol. 21, # 12,
[5] Patent: WO2018/169777, 2018, A1, . Location in patent: Paragraph 0227
[6] Patent: US2008/51397, 2008, A1, . Location in patent: Page/Page column 9; 21-22
[7] Patent: WO2011/47156, 2011, A1, . Location in patent: Page/Page column 89
[8] Journal of Organic Chemistry, 2002, vol. 67, # 7, p. 2160 - 2167
[9] Journal of Organic Chemistry, 2017, vol. 82, # 2, p. 1114 - 1126
[10] Farmaco, Edizione Scientifica, 1987, vol. 42, # 6, p. 409 - 424
[11] Organic Letters, 2013, vol. 15, # 4, p. 917 - 919
[12] Journal of the American Chemical Society, 2010, vol. 132, # 49, p. 17366 - 17369
[13] Chemistry - A European Journal, 2016, vol. 22, # 49, p. 17576 - 17580
[14] RSC Advances, 2013, vol. 3, # 45, p. 23119 - 23127
[15] Collection of Czechoslovak Chemical Communications, 2004, vol. 69, # 12, p. 2239 - 2252
[16] Organometallics, 2015, vol. 34, # 9, p. 1627 - 1634
[17] Patent: US2010/210593, 2010, A1, . Location in patent: Page/Page column 46
[18] Patent: EP2942346, 2015, A1, . Location in patent: Paragraph 0158
[19] Journal of Organic Chemistry, 1959, vol. 24, p. 1952,1954
[20] Journal of Medicinal Chemistry, 1987, vol. 30, # 1, p. 96 - 104
[21] Journal of Organic Chemistry, 1992, vol. 57, # 3, p. 965 - 969
[22] Chemical and Pharmaceutical Bulletin, 1997, vol. 45, # 2, p. 297 - 304
[23] Journal of Medicinal Chemistry, 2002, vol. 45, # 18, p. 3891 - 3904
[24] Journal of Medicinal Chemistry, 2003, vol. 46, # 3, p. 345 - 348
[25] Journal of Medicinal Chemistry, 2000, vol. 43, # 24, p. 4667 - 4677
[26] Patent: WO2004/43966, 2004, A1, . Location in patent: Page 49
[27] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 10, p. 3122 - 3125
[28] Patent: EP1577302, 2005, A1, . Location in patent: Page/Page column 116-117
[29] Journal of Medicinal Chemistry, 2009, vol. 52, # 10, p. 3317 - 3327
[30] Angewandte Chemie - International Edition, 2010, vol. 49, # 37, p. 6633 - 6637
[31] Chemistry - A European Journal, 2012, vol. 18, # 5, p. 1383 - 1400
[32] Chemistry - A European Journal, 2015, vol. 21, # 28, p. 10179 - 10184
[33] European Journal of Inorganic Chemistry, 2017, vol. 2017, # 13, p. 1845 - 1854
  • 2
  • [ 67853-03-6 ]
  • [ 1129-28-8 ]
YieldReaction ConditionsOperation in experiment
70% With phosphorus tribromide In diethyl ether for 2 h; To the solution of compound B4 (28 g, 0.168 mol) in 700 mL of Et2O was added PBr3 (17.4 mL, 0.185 mol) dropwise. The solution was stirred for 2 h, and then the reaction was poured into 500 mL of ice-water. The aqueous layer was extracted with Et2O. The combined organic layers were washed with sat. NaHCO3, water, and brine consecutively. The organic phase was dried over Na2SO4, filtered and concentrated under reduced pressure to give 34 g of compound B5 as an oil (yield: 70percent).
70% With phosphorus tribromide In diethyl ether Synthesis of Compound B5: [Show Image] To the solution of compound B4 (28 g, 0.168 mol) in 700 mL of Et2O was added PBr3 (17.4 mL, 0.185 mol) dropwise. The solution was stirred for 2 h, and then the reaction was poured into 500 mL of ice-water. The aqueous layer was extracted with Et2O. The combined organic layers were washed with sat. NaHCO3, water, and brine consecutively. The organic phase was dried over Na2SO4, filtered and concentrated under reduced pressure to give 34 g of compound B5 as an oil (yield: 70percent).
Reference: [1] Patent: WO2011/20615, 2011, A1, . Location in patent: Page/Page column 45; 47
[2] Patent: EP2289883, 2011, A1, . Location in patent: Page/Page column 18
[3] Journal of Medicinal Chemistry, 2007, vol. 50, # 7, p. 1711 - 1715
[4] Patent: EP1445249, 2004, A1, . Location in patent: Page 136
[5] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 2, p. 476 - 479
[6] Patent: WO2014/121931, 2014, A1, . Location in patent: Page/Page column 26
  • 3
  • [ 99-36-5 ]
  • [ 1129-28-8 ]
YieldReaction ConditionsOperation in experiment
96% With 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione; 2,2'-azobis(isobutyronitrile) In dichloromethane at 20℃; for 10 h; Heating / reflux Example 2: Preparation of Methyl 3-bromomethylbenzoate; To a solution of Methyl 3-methylbenzoate (150 g, I mol) and l,3-Dibromo-5,5-dimethyl hydantoin (DDH) (15O g, 0.52 mol) in dichloromethane (500 ml) was added AIBN (0.1 g, 0.0006 mol) at room temperature and heated under reflux for 1O h. AIBN in 0.1 g lots were added intermittently during reflux to complete the reaction. After completion of the reaction (monitored by TLC), the reaction mixture was poured into cold water (600 ml) and the organic layer was separated. The aqueous layer was extracted again with dichloromethane (200 ml). The combined organic layer was washed with water and dried over anhydrous sodium sulphate and the solvent was removed by distillation. Colorless liquid, 220 g (96 percent yield)Note: The product contains some dibromo derivative also. Benzoyl peroxide could be used as a radical initiator.
Reference: [1] Patent: WO2008/35379, 2008, A2, . Location in patent: Page/Page column 11
  • 4
  • [ 67-56-1 ]
  • [ 54267-06-0 ]
  • [ 1129-28-8 ]
YieldReaction ConditionsOperation in experiment
97% at 20℃; for 1 h; Reference example 2
Methyl 3-bromomethylbenzoate
3-Bromomethylbenzoyl chloride (1.96 g, 10.37 mmol) was dissolved in methanol (20 ml), and triethylamine (1.5 ml) was added thereto.
The mixture was stirred at room temperature for 1 hour.
The mixture was poured into a saturated sodium hydrogencarbonate solution and was extracted with dichloromethane.
The organic layer was dried over anhydrous magnesium sulfate and concentrated to give the captioned compound (1.90 g, 10.29 mmol, yield: 97percent) as a colorless oil.
Reference: [1] Patent: EP1550662, 2005, A1, . Location in patent: Page/Page column 20
[2] Organic and biomolecular chemistry, 2004, vol. 2, # 12, p. 1732 - 1741
  • 5
  • [ 67-56-1 ]
  • [ 6515-58-8 ]
  • [ 1129-28-8 ]
YieldReaction ConditionsOperation in experiment
94% at 25℃; for 1 h; Reflux To a solution of 3-Bromomethyl-benzoic acid (1 g, 4.6 mmol) in methanol (20 mL) was added thionyl chloride (1.1 g, 9.3 mmol) drop wise at 25 °C. The reaction mixture was refluxed over a period of 1 h and methanol was removed under reduced pressure to obtain crude sticky mass. The crude mass was diluted with ethyl acetate and washed with water and dried over sodium sulphate. Ethyl acetate was evaporated under reduced pressure to obtain 3-Bromomethyl-benzoic acid methyl ester as light yellow oil (1.0 g, 94.0 percent)
94% at 25℃; for 1 h; Reflux To a solution of 3-Bromomethyl-benzoic acid (1 g, 4.6 mmol) in methanol (20 mL) was added thionyl chloride (1.1 g, 9.3 mmol) drop wise at 25° C.
The reaction mixture was refluxed over a period of 1 h and methanol was removed under reduced pressure to obtain crude sticky mass.
The crude mass was diluted with ethyl acetate and washed with water and dried over sodium sulphate.
Ethyl acetate was evaporated under reduced pressure to obtain 3-Bromomethyl-benzoic acid methyl ester as light yellow oil (1.0 g, 94.0percent)
Reference: [1] Patent: WO2011/21209, 2011, A1, . Location in patent: Page/Page column 57; 58
[2] Patent: US2012/101099, 2012, A1, . Location in patent: Page/Page column 22; 23
  • 6
  • [ 1711-06-4 ]
  • [ 1129-28-8 ]
Reference: [1] Journal of the American Chemical Society, 1940, vol. 62, p. 1180,1181
[2] Organic and biomolecular chemistry, 2004, vol. 2, # 12, p. 1732 - 1741
[3] Farmaco, Edizione Scientifica, 1987, vol. 42, # 6, p. 409 - 424
[4] RSC Advances, 2013, vol. 3, # 45, p. 23119 - 23127
  • 7
  • [ 1877-71-0 ]
  • [ 1129-28-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 7, p. 1711 - 1715
[2] Patent: WO2011/20615, 2011, A1,
[3] Patent: EP2289883, 2011, A1,
[4] Patent: WO2012/71469, 2012, A2, . Location in patent: Page/Page column 95
[5] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 2, p. 476 - 479
  • 8
  • [ 99-04-7 ]
  • [ 1129-28-8 ]
Reference: [1] Patent: WO2011/21209, 2011, A1,
[2] Patent: US2012/101099, 2012, A1,
[3] Organic Letters, 2013, vol. 15, # 4, p. 917 - 919
[4] RSC Advances, 2013, vol. 3, # 45, p. 23119 - 23127
[5] Chemistry - A European Journal, 2015, vol. 21, # 28, p. 10179 - 10184
[6] Patent: CN106146413, 2016, A,
[7] European Journal of Inorganic Chemistry, 2017, vol. 2017, # 13, p. 1845 - 1854
  • 9
  • [ 121-91-5 ]
  • [ 1129-28-8 ]
Reference: [1] Patent: WO2011/20615, 2011, A1,
[2] Patent: EP2289883, 2011, A1,
  • 10
  • [ 1459-93-4 ]
  • [ 1129-28-8 ]
Reference: [1] Patent: WO2011/20615, 2011, A1,
[2] Patent: EP2289883, 2011, A1,
  • 11
  • [ 186581-53-3 ]
  • [ 6515-58-8 ]
  • [ 1129-28-8 ]
Reference: [1] Magnetic Resonance in Chemistry, 1989, vol. 27, # 6, p. 585 - 591
  • 12
  • [ 67-56-1 ]
  • [ 1711-06-4 ]
  • [ 1129-28-8 ]
Reference: [1] Chem.Abstr., 1964, vol. 60, # 15802,
[2] Chem.Abstr., 1965, vol. 62, # 14577,
[3] Chem.Abstr., 1966, vol. 65, # 5406,
  • 13
  • [ 870-50-8 ]
  • [ 1129-28-8 ]
  • [ 16466-61-8 ]
  • [ 1048669-58-4 ]
YieldReaction ConditionsOperation in experiment
74% With ammonium chloride; zinc In tetrahydrofuran; water for 3 h; General procedure: To 0.13 g (2 mmol) of Zn metal in 1 mL saturated aqueous NH4Cl solution was added 0.23 g (1 mmol) of 4. Stirring was begun and a solution of the appropriate benzyl bromide (2 mmol) in 2 mL of THF was added via pipette. The reaction vessel was capped and the mixture allowed to stir until the yellow color of 4 was discharged (generally ~3 h). The reaction mixture was filtered through a plug of glass wool into a centrifuge tube. The organic layer was removed. The aqueous layer was washed 2 × 2 mL of THF. The combined organic layers were dried over Na2SO4, filtered, and concentrated. Column chromatography on SiO2 using appropriate mixtures of ethylacetate and hexanes provided the desired compounds.
Reference: [1] Synthetic Communications, 2014, vol. 44, # 8, p. 1128 - 1136
  • 14
  • [ 1129-28-8 ]
  • [ 5689-33-8 ]
Reference: [1] Patent: US4638002, 1987, A,
  • 15
  • [ 1129-28-8 ]
  • [ 68432-92-8 ]
YieldReaction ConditionsOperation in experiment
91% With 18-crown-6 ether In acetonitrile at 20℃; for 72 h; (i) Production of methyl 3-(cyanomethyl)benzoate; To a solution of methyl 3-bromobenzoate (10.0 g, 44 mmol) in acetonitrile (100 mL) were added potassium cyanide (5.7 g, 87 mmol) and 18-crown-6 (1.0 g), and the mixture was stirred at room temperature for 3 days. The reaction mixture was filtered, and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate/hexane=5/95-->30/70), and the fraction containing the object product was concentrated under reduced pressure to give the title compound (7.0 g, 91percent) as a colorless oil. 1H-NMR (DMSO-d6, 300 MHz) δ 3.88 (3H, s), 4.17 (2H, s), 7.57 (1H, t, J = 7.6 Hz), 7.61 - 7.69 (1H, m), 7.88 - 7.95 (1H, m), 7.97 (1H, br s).
Reference: [1] Patent: EP2181987, 2010, A1, . Location in patent: Page/Page column 65; 110; 115
[2] Journal of Medicinal Chemistry, 2012, vol. 55, # 7, p. 3452 - 3478
[3] Angewandte Chemie - International Edition, 2010, vol. 49, # 37, p. 6633 - 6637
[4] Chemistry - A European Journal, 2012, vol. 18, # 5, p. 1383 - 1400
[5] Patent: WO2008/156820, 2008, A1, . Location in patent: Page/Page column 59
[6] Patent: WO2016/165014, 2016, A1, . Location in patent: Page/Page column 22
  • 16
  • [ 143-33-9 ]
  • [ 1129-28-8 ]
  • [ 68432-92-8 ]
YieldReaction ConditionsOperation in experiment
70% at 75℃; for 5 h; A suspension of methyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) arid sodium cyanide (4.33 g, 88.4 mmol) in DMf (25 ml) and water (1 ml) was stirred at 75 °C for 5 h. The reaction mixture was quenched with water (50 ml) and extracted with EtOAc (100 ml x 3). The combined orgaiiics were dried and concentrated under reduced pressure. The resulting residue was purified by column chromatography utilizing an ISCO system (hexane-EtOAc) to give 7.2 g (70percent) of colourless oil. NMR: 7.90 (s, I H), 7.86 (d, IH), 7.60 (d, IH), 7.50 (m, IH), 4.10 (s, 2H), 3.80 (s, 3H); m/z 175.
70% at 75℃; for 5 h; Method 1; 3-Cγanomethyl-benzoic acid methyl esterA suspension of methyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) and sodium cyanide (4.33 g5 88.4 mmol) in DMF (25 ml) and water (1 ml) was stirred at 75 °C for 5 h. The reaction mixture was quenched with water (50 ml) and extracted with EtOAc (100 ml x 3). The combined organics were dried (Na2SO4) and concentrated under reduced pressure. The resulting residue was purified by column chromatography utilizing an ISCO system (hexane-EtOAc) to give 7.2 g (70percent) of colourless oil. NMR: 7.90 (s5 IH), 7.86 (d, IH), 7.60 (d, IH)5 7.50 (m5 IH)5 4.10 (s, 2H)5 3.80 (s, 3H); m/z 175.
70%
Stage #1: at 75℃; for 5 h;
Stage #2: With water In N,N-dimethyl-formamide
A suspension of methyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) and sodium cyanide (4.33 g, 88.4 mmol) in DMF (25 ml) and water (1 ml) was stirred at 75 °C for 5 h. The reaction mixture was quenched with water (50 ml) and extracted with EtOAc (3 χ 100 ml). The combined organics were dried and concentrated under reduced pressure. The resulting residue was purified by column chromatography utilizing an ISCO system (hexane- EtOAc) to give7.2 g (70percent) of colourless oil. NMR: 7.90 (s, IH), 7.86 (d, IH), 7.60 (d, IH), 7.50 (m, IH), 4.10 (s, 2H), 3.80 (s, 3H); m/z 175.
70% at 75℃; for 5 h; A suspension of methyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) and sodium cyanide (4.33 g, 88.4 mmol) in DMF (25 ml) and water (1 ml) was stirred at 75 °C for 5 hours. The reaction mixture was quenched with water (50 ml) and extracted with EtOAc (100 ml x 3). The combined organics were dried with Na2SC>4(s) and concentrated under reduced pressure. The resulting residue was purified by column chromatography utilizing an ISCO system (hexane-EtOAc) to give7.2 g (70percent) of colourless oil. NMR (400 MHz): 7.90 (s, 1H), 7.86 (d, 1H), 7.60 (d, 1H), 7.50 (m, 1H), 4.10 (s, 2H), 3.80 (s, 3H); m/z 175.
70% at 75℃; for 5 h; Method 15; 3-Cvanomethyl-benzoic acid methyl ester; A suspension of methyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) and sodium cyanide (4.33 g, 88.4 mmol) in DMF (25 ml) and water (1 ml) was stirred at 75 °C for 5 hours. The reaction mixture was quenched with water (50 ml), extracted with EtOAc (3 x 100 <n="52"/>ml) and the combined organics were dried and concentrated under reduced pressure. The residue was purified by column chromatography utilizing an ISCO system (hexane-EtOAc) to give 7.2 g (70percent) of a colourless oil.1HNMR: 7.90 (s, IH), 7.86 (d, IH), 7.60 (d, IH), 7.50 (m, IH), 4.10 (s, 2H), 3.80 (s, 3H); m/z: 175.
70% at 75℃; for 5 h; Method 9; 3-Cvanomethyl-benzoic acid methyl ester; A suspension of niethyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) and sodium cyanide (4.33 g, 88.4 mmol) in DMF (25 ml) and water (1 ml) was stirred at 75 °C for 5 h. The reaction mixture was quenched with water and extracted with EtOAc. The combined organics were dried and concentrated under reduced pressure. The resulting residue was purified by column chromatography utilizing an ISCO system (hexane-EtOAc) to give 7.2 g (70percent) of colourless oil. NMR: 7.90 (s, IH), 7.86 (d, IH), 7.60 (d, IH), 7.50 (m, IH), 4.10 (s, 2H), 3.80 (s, 3H); m/z 175.
70% at 75℃; for 5 h; Method 2
3-Cyanomethyl-benzoic acid methyl ester
A suspension of methyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) and sodium cyanide (4.33 g, 88.4 mmol) in DMF (25 ml) and water (1 ml) was stirred at 75 ° C. for 5 h.
The reaction mixture was quenched with water and extracted with EtOAc.
The combined organics were dried with NaCl(sat) and then Na2SO4(s).
The solvents were removed under reduced pressure.
The resulting residue was purified by column chromatography utilizing an 20 ISCO system (hexane-EtOAc) to give 7.2 g (70percent/o) of colourless oil. NMR: 7.90 (s, 1H); 7.86 (d, 1H); 7.60 (d, 1H); 7.50 (m, 1H); 4.10 (s, 2H); 3.80 (s, 3H); m/z 175.
70% at 75℃; for 5 h; Method 50; 3-Cyanomethylbenzoic acid methyl ester; A suspension of methyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) and sodiumcyanide (4.33 g, 88.4 mmol) in DMF (25 ml) and water (1 ml) was stirred at 75 °C for 5hours. The reaction mixture was quenched with water (50 ml) and extracted with EtOAc (100ml x 3). The combined organics were dried with Na2SO4(s) and concentrated under reducedpressure. The resulting residue was purified by column chromatography utilizing an ISCOsystem (hexane-EtOAc) to give7.2 g (70percent) of colourless.oil. NMR (400 MHz): 7.90 (s, 1 H),7.86 (d, 1 H), 7.60 (d, 1 H), 7.50 (m, 1 H)3 4.10 (s, 2 H), 3.80 (s, 3 H); m/z 175.
70% at 75℃; for 5 h; Method 12; 3-Cvanomethyl-benzoic acid methyl ester; A suspension of methyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) and sodium cyanide (4.33 g, 88.4 mmol) in DMF (25 ml) and water (1 ml) was stirred at 75 0C for 5 hours. The reaction mixture was quenched with water (50 ml) and extracted with EtOAc. The combined organics were dried and concentrated under reduced pressure. The resulting residue was purified by column chromatography utilizing an ISCO system (hexane-EtOAc) to give 7.2 g (70percent) of colourless oil. NMR: 7.90 (s, 1Η), 7.86 (d, 1Η), 7.60 (d, 1Η), 7.50 (m, 1Η), 4.10 (s, 2Η), 3.80 (s, 3H); m/z 175.
70% at 75℃; for 5 h; Method 6; 3-Cyanomethyl-benzoic acid methyl ester; A suspension of methyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) and sodium cyanide (4.33 g, 88.4 mmol) in DMF (25 ml) and water (1 ml) was stirred at 75 0C for 5 h. The reaction mixture was quenched with water and extracted with EtOAc. The combined <n="28"/>organics were dried with NaCl(sat) and then Na2S O4(s). The solvents were removed under reduced pressure. The resulting residue was purified by column chromatography utilizing an ISCO system (hexane-EtOAc) to give 7.2 g (70percent) of colourless oil. NMR: 7.90 (s, IH), 7.86 (d, IH), 7.60 (d, IH), 7.50 (m, IH), 4.10 (s, 2H), 3.80 (s, 3H); m/z 175.
70% at 75℃; for 5 h; Method 4; 3-Cyanomethyl-benzoic acid methyl ester; A suspension of methyl-3-(bromomethyl)benzoate (13.5 g, 58.9 mmol) and sodium cyanide (4.33 g, 88.4 mmol) in DMF (25 ml) and water (1 ml) was stirred at 75 °C for 5 hours. The reaction mixture was quenched with water (50 ml) and extracted with EtOAc (3 x 100 ml). The combined organics were dried with Na2S04(s) and concentrated under reduced pressure. The resulting residue was purified by column chromatography utilizing an ISCO system (hexane-EtOAc) to give 7.2 g (70percent) of a colourless oil.

Reference: [1] Patent: WO2006/67446, 2006, A1, . Location in patent: Page/Page column 126
[2] Patent: WO2006/79791, 2006, A1, . Location in patent: Page/Page column 34
[3] Patent: WO2006/24834, 2006, A1, . Location in patent: Page/Page column 63-64
[4] Patent: WO2006/24836, 2006, A1, . Location in patent: Page/Page column 27
[5] Patent: WO2007/71955, 2007, A1, . Location in patent: Page/Page column 50-51
[6] Patent: WO2007/71963, 2007, A2, . Location in patent: Page/Page column 47
[7] Patent: US2009/170849, 2009, A1, . Location in patent: Page/Page column 11
[8] Patent: WO2006/3378, 2006, A1, . Location in patent: Page/Page column 64
[9] Patent: WO2006/40568, 2006, A1, . Location in patent: Page/Page column 62
[10] Patent: WO2007/113557, 2007, A1, . Location in patent: Page/Page column 26-27
[11] Patent: WO2005/123696, 2005, A1, . Location in patent: Page/Page column 66
[12] Journal of Medicinal Chemistry, 2003, vol. 46, # 3, p. 345 - 348
[13] Patent: WO2008/97341, 2008, A2, . Location in patent: Page/Page column 46-47
[14] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 3, p. 1026 - 1029
  • 17
  • [ 773837-37-9 ]
  • [ 1129-28-8 ]
  • [ 68432-92-8 ]
YieldReaction ConditionsOperation in experiment
89% at 20℃; Step 1: synthesis of methyl 3-(cyanomethyl)benzoate (1)To a solution of 3-(bromomethyl)benzoic acid methyl ester (25 g, 109 mmol) in DMF (250 mL) was added NaCN (5.4 g, 109 mmol). The reaction mixture was stirred overnight at rt. The mixture was poured into water (1.5 L), followed by the extraction with TBME (2 x 500mL). The combined organic layers were washed with water, brine, dried (Na2S04), filtered and evaporated under reduced pressure to yield methyl 3- (cyanomethyl)benzoate 1 (17g, 89percent). 1H-NMR (400 MHz, CDC13) 3.82 (s, 2H), 3.94 (s, 3H), 7.48 (m, 1H), 7.57 (m, 1H), 8.03 (m, 2H).
89% at 20℃; Step 1:
synthesis of methyl 3-(cyanomethyl)benzoate (1)
To a solution of 3-(bromomethyl)benzoic acid methyl ester (25 g, 109 mmol) in DMF (250 mL) was added NaCN (5.4 g, 109 mmol).
The reaction mixture was stirred overnight at rt.
The mixture was poured into water (1.5 L), followed by the extraction with TBME (2*500 mL).
The combined organic layers were washed with water, brine, dried (Na2SO4), filtered and evaporated under reduced pressure to yield methyl 3-(cyanomethyl)benzoate 1 (17 g, 89percent).
1H-NMR (400 MHz, CDCl3) 3.82 (s, 2H), 3.94 (s, 3H), 7.48 (m, 1H), 7.57 (m, 1H), 8.03 (m, 2H).
85% at 75℃; for 5 h; Inert atmosphere A suspension of methyl-3-(bromomethyl)benzoate (0.5 g, 2.18 mmol) and sodium cyanide (0.16 g, 3.27 mmol) in DMF (0.93 mL) and H2O (0.04 mL) was stirred at 75 °C for 5 h. The reaction was quenched with water and extracted with EtOAc. The combined organic layers were washed with H2O (3×), dried (Na2SO4) and the solvents were evaporated. The residue was purified by column chromatography (silica gel, from 80:20 hexane/EtOAc to 70:30 hexane/EtOAc) to afford 0.324 g (85percent) of a colourless oil identified as methyl 3-(cyanomethyl)benzoate 29b. 1H NMR (400.13 MHz, CDCl3): δ 8.02–8.00 (m, 2H, ArH), 7.56–7.53 (m, 1H, ArH), 7.50–7.46 (m, 1H, ArH), 3.93 (s, 3H, CH3), 3.81 (s, 2H, CH2) ppm. 13C NMR (100.62 MHz, CDCl3): δ 166.3 (s), 132.3 (d), 131.0 (s), 130.5 (s), 129.3 (d), 129.2 (d), 129.1 (d), 117.5 (s), 52.3 (q), 23.4 (t) ppm. HMRS (ESI+): Calcd for C10H10NO2 ([M+H]+), 176.0706; found, 176.0703. IR (NaCl): ν 3003 (w, C–H), 2954 (w, C–H), 2252 (w, CN), 1722 (s, CO), 1439 (m), 1287 (m) cm−1. UV (MeOH): λmax 283, 229 nm.
81% at 65℃; for 2 h; Methyl 3-(cyanomethyl)benzoate 15. To a stirring aqueous solution (60 mL) of potassium cyanide (3.62 g, 55.7 mmol) at 65°C was added dropwise methyl 3-(bromomethyl)benzoate 14 (10.2 g, 44.5 mmol) in absolute ethanol (50 mL) over a period of 0.5 h. After addition, the reaction was stirred for 1.5 h at 65°C. The solution was then diluted with absolute ethanol (500 mL), cooled on ice bath, filtered, and concentrated with a rotary evaporator. The crude was treated with chloroform (350 mL), dried over MgS04, filtered, concentrated, and used without further purification. Yield 6.3 g (81percent). 3/4-NMR (CDC13): 3.81 br s (2H, CH2), 3.93 s (3H, CH3); 7.45-7.51 m (1H, CH), 7.53-7.58 m (1H, CH), 7.99-8.04 m (2H, CH).
51% at 0 - 10℃; for 3.25 h; To a cold solution of Intermediate BM (7.2 g, 31.44 mmol) in DMSO (35.0 mL) at 0 °C was added a sodium cyanide (3.0 g, 62.88 mmol) portionwise over 15 minutes. After the addition was complete, the reaction mixture was allowed to stir at 10 °C for 3 hours. Ice cold water was added to the reaction mixture (50 mL), and the reaction was extracted with ethyl acetate (3 χ 50 mL), washed with water (2 χ 25 mL) and brine (25 mL), dried over anhydrous Na2S04, and the solvent was removed to afford the crude product. This material was purified by column chromatography (silica gel 100-200 mesh) using 10percent ethyl acetate in petroleum ether as the eluent to afford Intermediate BN (2.8 g, 51percent) as a pale brown liquid. NMR (CDC13): δ 9.44-9.42 (m, 2H), 8.90-8.78 (m, 2H), 4.63 (s, 3H), 4.49 (s, 2H). Mass (M-H): 174.1.

Reference: [1] Patent: WO2011/147764, 2011, A1, . Location in patent: Page/Page column 25
[2] Patent: US2013/79341, 2013, A1, . Location in patent: Paragraph 0104
[3] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 7, p. 2056 - 2067
[4] Patent: WO2012/173784, 2012, A1, . Location in patent: Page/Page column 28-29
[5] Journal of Organic Chemistry, 2017, vol. 82, # 2, p. 1114 - 1126
[6] Patent: WO2011/47156, 2011, A1, . Location in patent: Page/Page column 89
[7] Patent: US2009/275583, 2009, A1, . Location in patent: Page/Page column 30
  • 18
  • [ 151-50-8 ]
  • [ 1129-28-8 ]
  • [ 68432-92-8 ]
YieldReaction ConditionsOperation in experiment
96% With 18-crown-6 ether In acetonitrile for 24 h; Heating / reflux To methyl 3-bromomethyl-benzoate (25.28 g, 0.11 mol) in acetonitrile (230 ml) is added potassiumcyanide (14.3 g, 0.22 mmol) and 18-crown-6 (1.00 g, 2.6 mmol) and the mixture is heated to reflux for24 h. After filtration, the crude product is transferred to the next step without any further purification.Yield: 18.5 g (96 percent)
68% at 60℃; a) methyl 3-(cyanomethyl)benzoateA slurry of methyl 3-(bromomethyl)benzoate (4.0 g, 17.5 mmol) and potassium cyanide (1.2 g, 18.4 mmol) in ethanol (40 ml) was heated at 60 °C over night, filtrated and evaporated. The residue was purified using column chromatography on SiO2 affording 2.1 g (68percent) of the title compound.1H NMR (399.988 MHz, CDC13) δ 8.06 - 7.98 (m, 2H), 7.56 (d, J= 8.0 Hz, IH), 7.51 - 7.46 (m, IH), 3.94 (s, 3H), 3.82 (s, 2H)
Reference: [1] Patent: WO2006/589, 2006, A1, . Location in patent: Page/Page column 56-57
[2] Journal of Medicinal Chemistry, 1997, vol. 40, # 25, p. 4030 - 4052
[3] Organic and biomolecular chemistry, 2004, vol. 2, # 12, p. 1732 - 1741
[4] Patent: WO2007/30061, 2007, A1, . Location in patent: Page/Page column 83
  • 19
  • [ 1129-28-8 ]
  • [ 68432-92-8 ]
Reference: [1] Patent: US2009/137595, 2009, A1,
[2] Patent: US2002/2152, 2002, A1,
[3] Patent: US5523302, 1996, A,
[4] Patent: EP1445249, 2004, A1, . Location in patent: Page 136
[5] Patent: US6288120, 2001, B1,
[6] Patent: US6344485, 2002, B1,
  • 20
  • [ 7677-24-9 ]
  • [ 1129-28-8 ]
  • [ 68432-92-8 ]
YieldReaction ConditionsOperation in experiment
43% With tetrabutyl ammonium fluoride In acetonitrile for 20 h; Heating / reflux To an ice-cold solution of methyl 3-bromomethylbenzoate (9.1 g, 40 mmol) in CH3CN (108 mL) was added tetrabutylammonium fluoride (17.3 ML, 60 mmol) and trimethylsilylcyanide (8.0 ML, 60 mmol), and the reaction mixture was heated at reflux for 20 h. The reaction mixture was cooled to room temperature, and the solvent was removed under reduced pressure. Purification by flash column chromatography (silica, 1: 1 EtOAc/hexanes) provided methyl 3-cyanomethylbenzoate as a clear oil (3.0 g, 43percent) :H NMR (300 MHz, DMSO-d6) 8 7.97 (s, 1H), 7.92 (D, J = 8 Hz, 1H), 7.64 (D, J = 8 Hz, 1H), 7.56 (T, J = 8 Hz, 1H), 4.16 (s, 2H), 3.87 (s, 3H).
43% With tetrabutyl ammonium fluoride In acetonitrile for 20 h; Heating / reflux To an ice-cold solution of methyl 3-bromomethylbenzoate (9.1 g, 40 mmol) in CH3CN (108 mL) was added tetrabutylammonium fluoride (17.3 ML, 60 mmol) and trimethylsilylcyanide (8.0 ML, 60 mmol), and the reaction mixture was heated at reflux for 20 h. The reaction mixture was cooled to room temperature, and the solvent was removed under reduced pressure. Purification by flash column chromatography (silica, 1: 1 EtOAc/hexanes) provided methyl 3-cyanomethylbenzoate as a clear oil (3.0 g, 43percent) :H NMR (300 MHz, DMSO-d6) 8 7.97 (s, 1H), 7.92 (D, J = 8 Hz, 1H), 7.64 (D, J = 8 Hz, 1H), 7.56 (T, J = 8 Hz, 1H), 4.16 (s, 2H), 3.87 (s, 3H).
Reference: [1] Synlett, 2009, # 8, p. 1291 - 1294
[2] Patent: WO2005/18557, 2005, A2, . Location in patent: Page/Page column 299
[3] Patent: WO2005/18557, 2005, A2, . Location in patent: Page/Page column 299
  • 21
  • [ 1129-28-8 ]
  • [ 2084-13-1 ]
Reference: [1] Patent: WO2012/173784, 2012, A1,
  • 22
  • [ 124-41-4 ]
  • [ 1129-28-8 ]
  • [ 32194-76-6 ]
YieldReaction ConditionsOperation in experiment
96%
Stage #1: at 20 - 50℃; for 2 h; Inert atmosphere
Stage #2: With water; potassium hydroxide In methanol at 50℃; for 1.5 h;
Stage #3: With hydrogenchloride In methanol; water at 20℃;
a) 3-(Methoxymethyl)benzoic acid; To a solution of methyl 3-(bromomethyl)benzoate (1129-28-8, 1.05 g, 4.6 mmol) in dry MeOH (30 ml) under argon at rt was added sodium methanolate (0.74 g, 13.8 mmol). The suspension was stirred at 50° C. for 2 hr and then aqueous KOH (5M) was added and the mixture again stirred at 50° C. for 1.5 hr.After cooling to rt aqueous HCl was added to adjust the pH to 2-3. The aqueous phase was extracted with ethyl acetate, the organic phase dried over sodium sulfate, and the solvent was evaporated under reduced pressure to afford the title compound as a colorless oil (749 mg, 96percent). LCMS RtB=2.47 min; [M+H]+=167.0]
96%
Stage #1: at 20 - 50℃; for 2 h; Inert atmosphere
Stage #2: With water; potassium hydroxide In methanol at 50℃; for 1.5 h;
Stage #3: With hydrogenchloride In methanol; water at 20℃;
Building Block B3.1: 4-Bromomethyl-5-(3-methoxymethyl-phenyl)-oxazole a) 3-(Methoxymethyl)benzoic acid To a solution of methyl 3-(bromomethyl)benzoate, 1.05 g, 4.6 mmol) in dry MeOH (30 ml) under argon at rt was added sodium methanolate (0.74 g, 13.8 mmol). The suspension was stirred at 50° C. for 2 hr and then aqueous KOH (5M) was added and the mixture again stirred at 50° C. for 1.5 hr.After cooling to rt aqueous HCl was added to adjust the pH to 2-3. The aqueous phase was extracted with ethyl acetate, the organic phase dried over sodium sulfate, and the solvent was evaporated under reduced pressure to afford the title compound as colorless oil (749 mg, 96percent). LCMS RtB=2.47 min; [M+H]+=167.0]
96%
Stage #1: at 50℃; for 2 h;
Stage #2: With water; potassium hydroxide In methanol at 50℃; for 1.5 h;
Stage #3: With hydrogenchloride In methanol; water at 20℃;
To a solution of methyl 3-(bromomethyl)benzoate, 1 .05 g, 4.6 mmol) in dry MeOH (30 ml) under argon at rt was added sodium methanolate (0.74g, 13.8 mmol). The suspension was stirred at 50 °C for 2 hr and then aqueous KOH (5M) was added and the mixture again stirred at 50 °C for 1 .5 hr.After cooling to rt aqueous HCI was added to adjust the pH to 2-3. The aqueous phase was extracted with ethyl acetate, the organic phase dried over sodium sulfate, and the solvent was evaporated under reduced pressure to afford the title compound as colorless oil (749 mg, 96percent). LCMS RtB = 2.47 min; [M+H]+ = 167.0]
Reference: [1] Patent: US2012/101110, 2012, A1, . Location in patent: Page/Page column 70
[2] Patent: US2012/165331, 2012, A1, . Location in patent: Page/Page column 27-28
[3] Patent: WO2012/101487, 2012, A1, . Location in patent: Page/Page column 65; 66
  • 23
  • [ 1129-28-8 ]
  • [ 67853-03-6 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 15, p. 2997 - 3001
  • 24
  • [ 1129-28-8 ]
  • [ 28286-79-5 ]
Reference: [1] Journal of Organic Chemistry, 1993, vol. 58, # 23, p. 6372 - 6376
  • 25
  • [ 1129-28-8 ]
  • [ 117445-22-4 ]
Reference: [1] Patent: WO2011/21209, 2011, A1,
[2] Patent: US2012/101099, 2012, A1,
  • 26
  • [ 1129-28-8 ]
  • [ 82072-22-8 ]
YieldReaction ConditionsOperation in experiment
91% With diisobutylaluminium hydride In toluene at 0 - 20℃; for 2 h; Inert atmosphere Step A: To a stirred solution of methyl 3-(bromomethyl)benzoate (5 g, 21.8 mmol) in toluene (50 mL) was added DABAL-H (43.6 ml, 43.6 mmol) in an ice bath. The reaction was stirred at 0 °C for 2 hours. The mixture was quenched with 1 N HCl, extracted with EtOAc and water. The organic layer was dried over anhydrous Na2S04 and concentrated to afford (3-(bromomethyl)phenyl)methanol (4.0 g, 19.9 mmol, 91percent yield) as a colorless oil.
91% With diisobutylaluminium hydride In toluene at 0℃; for 2 h; To a stirred solution of methyl 3-(bromomethyl)benzoate (5 g, 21.8 mmol) in toluene (50 mL) was added DABAL-H (43.6 ml, 43.6 mmol) in an ice bath. The reaction was stirred at 0 °C for 2 hours. The mixture was quenched with 1 N HC1, extracted with EtOAc and water. The organic layer was dried over anhydrous Na2S04 and concentrated to afford (3-(bromomethyl)phenyl)methanol (4.0 g, 19.9 mmol, 91percent yield) as a colorless oil.
68% With diisobutylaluminium hydride In toluene at -30℃; for 2.5 h; To a solution of methyl 3-(bromomethyl)benzoate (0.5 g, 2.2 mmol) dissolved in dry toluene (10 mL), cooled to -30°C, 1M solution of DIBAL-H in toluene (4.3 mL, 4.4 mmol) was dropped. The reaction mixture was stirred at -30°C for 2.5h and then allowed to warm to ambient temperature. The reaction mixture was quenched with methanol, filtered, extracted with ethyl acetate, washed with aqueous sodium bicarbonate solution, then brine, dried over sodium sulfate, and evaporated under reduced pressure giving 3-bromomethylbenzyl alcohol (0.3 g); yield 68percent.
Reference: [1] Organometallics, 2015, vol. 34, # 9, p. 1627 - 1634
[2] Patent: WO2015/142903, 2015, A2, . Location in patent: Page/Page column 94
[3] Patent: WO2015/140133, 2015, A1, . Location in patent: Page/Page column 106
[4] Patent: WO2017/68064, 2017, A1, . Location in patent: Page/Page column 191; 192
[5] Patent: EP2816023, 2014, A1, . Location in patent: Paragraph 0488
  • 27
  • [ 1129-28-8 ]
  • [ 226070-69-5 ]
Reference: [1] Patent: WO2011/21209, 2011, A1,
[2] Patent: US2012/101099, 2012, A1,
  • 28
  • [ 1129-28-8 ]
  • [ 811801-40-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 23, p. 5867 - 5872
  • 29
  • [ 110-91-8 ]
  • [ 1129-28-8 ]
  • [ 67451-81-4 ]
YieldReaction ConditionsOperation in experiment
41% With sodium hydroxide In methanol; dichloromethane EXAMPLE 14
3-Morpholin-4-yl-methyl-benzoic Acid
Commercially available methyl 3-bromomethyl benzoate (5 g, 22 mmole) was dissolved in dichloromethane (20 mL) and morpholine (3.93 mL, 45 mmol) was added.
The solution was allowed to stir for 12 h, and filtered.
The solvent of the filtrate was removed under reduced pressure.
The resulting crude ester was dissolved in methanol, and sodium hydroxide (4.6 mL of 5N solution) was added.
The solution was stirred overnight at 40° C. for 12 h.
The solvent was partially removed under reduced pressure.
The crude was acidified, dichloromethane was added and the solution was cooled in ice.
After one hour, it was filtered, to provide the title product (2.3 g, 41percent) as the white solid hydrochloride salt: 1H-NMR (DMSO-d6) δ13.1 (bs, 1H), 11.8 (bs, 1H), 8.14 (s, 1H), 7.92 (m, 2H), 7.65 (t, J=4 Hz, 1H), 4.39 (bs, 2H), 3.91(m, 4H), 3.12 (m, 4H). MS (EI-NEG):[M+]221; Anal.RP-HPLC: 99percent purity.
Reference: [1] Patent: US6355633, 2002, B1,
  • 30
  • [ 1129-28-8 ]
  • [ 67451-81-4 ]
Reference: [1] Patent: WO2018/169777, 2018, A1,
  • 31
  • [ 1129-28-8 ]
  • [ 775304-60-4 ]
Reference: [1] Advanced Synthesis and Catalysis, 2017, vol. 359, # 10, p. 1708 - 1716
  • 32
  • [ 1129-28-8 ]
  • [ 180863-55-2 ]
Reference: [1] Patent: WO2011/21209, 2011, A1,
[2] Patent: US2012/101099, 2012, A1,
  • 33
  • [ 75-16-1 ]
  • [ 1129-28-8 ]
  • [ 136279-23-7 ]
YieldReaction ConditionsOperation in experiment
40% at 0 - 45℃; for 2 h; To a solution of methyl 3- (bromomethyl)benzoate (0.5 g, 2.18 mmol) in ether (10 mL), at 0 °C was added dropwise methylmagnesium bromide (3M in Et20, 2.18 mL, 6.55 mmol). The reaction mixture was warmed up to 45 °C and stirred for 2 h, and then poured into an ice-cooled saturated aq. solution of NH4CI and extracted with EtOAc. The organic layer was washed with brine, dried over Na2S04, filtered, and concentrated under reduced pressure. The residue was purified by Si02gel chromatography (8percent to 60percent EtOAc/Hexanes) to give 2-(3-(bromomethyl)phenyl)propan-2-ol as a clear oil (202 mg, 40percent). MS (ES+) Ci0H13BrO requires: 229, found: 229/231 [M+H]+.
Reference: [1] Patent: WO2014/31928, 2014, A2, . Location in patent: Paragraph 0344
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1129-28-8 ]

Aryls

Chemical Structure| 16281-97-3

[ 16281-97-3 ]

Methyl 4-(1-bromoethyl)benzoate

Similarity: 0.90

Chemical Structure| 108052-76-2

[ 108052-76-2 ]

tert-Butyl 4-(bromomethyl)benzoate

Similarity: 0.90

Chemical Structure| 6515-58-8

[ 6515-58-8 ]

3-(Bromomethyl)benzoic acid

Similarity: 0.89

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.88

Chemical Structure| 877624-40-3

[ 877624-40-3 ]

Methyl 3-bromo-5-(bromomethyl)benzoate

Similarity: 0.88

Bromides

Chemical Structure| 16281-97-3

[ 16281-97-3 ]

Methyl 4-(1-bromoethyl)benzoate

Similarity: 0.90

Chemical Structure| 108052-76-2

[ 108052-76-2 ]

tert-Butyl 4-(bromomethyl)benzoate

Similarity: 0.90

Chemical Structure| 6515-58-8

[ 6515-58-8 ]

3-(Bromomethyl)benzoic acid

Similarity: 0.89

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.88

Chemical Structure| 877624-40-3

[ 877624-40-3 ]

Methyl 3-bromo-5-(bromomethyl)benzoate

Similarity: 0.88

Esters

Chemical Structure| 16281-97-3

[ 16281-97-3 ]

Methyl 4-(1-bromoethyl)benzoate

Similarity: 0.90

Chemical Structure| 108052-76-2

[ 108052-76-2 ]

tert-Butyl 4-(bromomethyl)benzoate

Similarity: 0.90

Chemical Structure| 78471-43-9

[ 78471-43-9 ]

Methyl 4-bromo-2-bromomethylbenzoate

Similarity: 0.88

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.88

Chemical Structure| 877624-40-3

[ 877624-40-3 ]

Methyl 3-bromo-5-(bromomethyl)benzoate

Similarity: 0.88

Benzyl Bromides

Chemical Structure| 16281-97-3

[ 16281-97-3 ]

Methyl 4-(1-bromoethyl)benzoate

Similarity: 0.90

Chemical Structure| 108052-76-2

[ 108052-76-2 ]

tert-Butyl 4-(bromomethyl)benzoate

Similarity: 0.90

Chemical Structure| 6515-58-8

[ 6515-58-8 ]

3-(Bromomethyl)benzoic acid

Similarity: 0.89

Chemical Structure| 114772-38-2

[ 114772-38-2 ]

Methyl 2-[4-(Bromomethyl)phenyl]benzoate

Similarity: 0.88

Chemical Structure| 877624-40-3

[ 877624-40-3 ]

Methyl 3-bromo-5-(bromomethyl)benzoate

Similarity: 0.88